Key result
Therapeutic Spp1 silencing in TREM2+ cardiac macrophages suppresses atrial fibrillation.
Why the study?
Does therapeutic Spp1 silencing in TREM2+ cardiac macrophages suppress atrial fibrillation?
Does therapeutic Spp1 silencing in TREM2+ cardiac macrophages suppress atrial fibrillation?
Therapeutic Spp1 silencing in TREM2+ cardiac macrophages may offer a novel approach to suppress atrial fibrillation by targeting fibrosis.
Answers are grounded in this paper and cite their sources.
May support macrophage-targeted AF therapy; hypothesis-generating and requires validation before clinical translation.
Atrial fibrillation and the risk of its lethal complications are propelled by fibrosis, which induces electrical heterogeneity and gives rise to reentry circuits.
No takes yet. Share an insight, caveat, or question.
Momin et al. (2026) studied this question. Therapeutic Spp1 silencing in TREM2+ cardiac macrophages suppresses atrial fibrillation.
Synapse has enriched 10 related papers. Consider them for comparative context: